Deregulation of erythropoiesis by the Friend spleen focus-forming virus

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 10, 1999, Pages 1089-1109

  Ruscetti, Sandra K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epo receptor; Epo signal transduction pathways; Erythroleukemia; Friend spleen focus forming virus; Viral envelope glycoprotein

Indexed keywords

ENVELOPE PROTEIN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; STAT1 PROTEIN;

CELL HYPERPLASIA; CELL TRANSFORMATION; DIMERIZATION; ERYTHROID PRECURSOR CELL; ERYTHROLEUKEMIA; ERYTHROPOIESIS; GENETIC TRANSCRIPTION; HUMAN; MOUSE; NONHUMAN; PATHOGENICITY; REVIEW; SIGNAL TRANSDUCTION; SPLEEN FOCUS FORMING VIRUS;

EID: 0032867332     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00074-6     Document Type: Article

References (162)

1. Friend C. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. Journal of Experimental Medicine. 105:1957;307-318.
2. Kabat D. Molecular biology of Friend viral erythroleukemia. Current Topics in Microbiology and Immunology. 148:1989;1-42.
3. Ben-David Y., Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell. 66:1991;831-834.
4. D'Andrea A.D. The interaction of the erythropoietin receptor and gp55. Witte O.N. Cancer Surveys. vol. 15:1992;19-36 Cold Spring Harbor Press, New York.
5. Johnson P., Benchimol S. Friend virus induced murine erythroleukemia: the p53 locus. Witte O.N. Cancer Surveys. vol. 12:1992;137-151 Cold Spring Harbor Press, Cold Spring Harbor.
6. Ruscetti S.K. Friend spleen focus-forming virus. Young N.S. Viral Infection of the Bone Marrow: Basic and Clinical Aspects. 1993;289-313 Marcel Dekker, New York.
7. Ruscetti S.K. Erythroleukemia induction by the Friend spleen focus-forming virus. Young N. Viruses as Agents of Haematological Diseases, Bailliere's Clinical Haematology. vol. 8:1:1995;225-247 Bailliere Tindall, London.
8. Hoatlin M.E., Kabat D. Host-range control of a retroviral disease: Friend erythroleukemia. Trends in Microbiology. 3:1995;51-57.
9. Mirand E.A., Steeves R.A., Ayila L., Grace J.T. Spleen focus formation by polycythemic strains of Friend leukemia virus. Proceedings of the Society for Experimental Biology and Medicine. 127:1968;900-904.
10. Sassa S., Takaku F., Nakao K. Regulation of erythropoiesis in the Friend leukemia mouse. Blood. 31:1968;758-765.
11. Horoszewicz J.S., Leong S.S., Carter W.A. Friend leukemia: rapid development of erythropoietin-independent hematopoietic precursors. Journal of the National Cancer Institute. 54:1975;265-267.
12. Liao S., Axelrad A.A. Erythropoietin-independent erythroid colony formation in vitro by hematopoietic cells of mice infected with Friend virus. International Journal of Cancer. 15:1975;467-482.
13. Tambourin P., Wendling F. Malignant transformation and erythroid differentiation by polycythaemia-inducing Friend virus. Nature. 234:1971;230-233.
14. Axelrad A.A., Steeves R.A. Assay for Friend leukemia virus: rapid quantitative method based on enumeration of macroscopic spleen foci in mice. Virology. 24:1964;513-518.
15. Steinheider G., Seidel H.J., Kreja L. Comparison of the biological effects of anemia inducing and polycythemia inducing Friend virus complex. Experientia. 35:1979;1173-1175.
16. Tambourin P.E., Wendling F., Jasmin C., Smadja-Joffe F. The physiopathology of Friend leukemia. Leukemia Research. 3:1979;117-129.
17. Kost T.A., Koury M.J., Hankins W.D., Krantz S.B. Target cells for Friend virus-induced erythroid bursts in vitro. Cell. 18:1979;145-152.
18. Tambourin P., Wendling F. Target cell for oncogenic action of polycythaemia-inducing Friend virus. Nature. 256:1975;320-322.
19. Lilly F. Fv-2: identification and location of a second gene governing the spleen focus response of Friend leukemia in mice. Journal of the National Cancer Institute. 45:1970;163-169.
20. s bone marrow. Journal of Experimental Medicine. 154:1981;126-137.
21. Behringer R.R., Dewey M.J. Cellular site and mode of Fv-2 gene action. Cell. 40:1985;441-447.
22. Evans L.H., Duesberg P.H., Scolnick E.M. Replication of spleen focus-forming virus in fibroblasts from C57BL mice that are genetically resistant to spleen focus formation. Virology. 101:1980;534-539.
23. Eckner R.J., Hettrick K.L. Chronic infection of Fv-2 resistant hematopoietic cells by Friend spleen focus-forming virus. Virology. 122:1982;171-185.
24. Van der Gaag H.C., Axelrad A.A. Friend virus replication in normal and immunosuppressed C57BL/6 mice. Virology. 177:1990;837-839.
25. Suzuki S., Axelrad A.A. Fv-2 locus controls the proportion of erythropoietic progenitor cells (BFU-E) synthesizing DNA in normal mice. Cell. 19:1980;225-236.
26. Hankins W.D., Kost T.A., Koury M.J., Krantz S.B. Erythroid bursts produced by Friend leukemia virus in vitro. Nature. 276:1978;506-508.
27. Hankins W.D., Troxler D. Polycythemia- and anemia-inducing erythroleukemia viruses exhibit differential erythroid transforming effects in vitro. Cell. 22:1980;693-699.
28. Constantinescu S.N., Wu H., Liu X., Beyer W., Fallon A., Lodish H.F. The anemic Friend virus gp55 envelope protein induces erythroid differentiation in fetal liver colony-forming units-erythroid. Blood. 91:1998;1163-1172.
29. Ruscetti S.K., Janesch N.J., Chakraborti A., Sawyer S.T., Hankins W.D. Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line. Journal of Virology. 63:1990;1057-1062.
30. r resistance gene. Proceedings of the National Academy of Sciences of the USA. 87:1990;9985-9989.
31. Li J., D'Andrea A.D., Lodish H.F., Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature. 343:1990;762-764.
32. Showers M.O., DeMartino J.C., Saito Y., D'Andrea A.D. Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line. Molecular and Cellular Biology. 13:1993;739-748.
33. Hoatlin M.E., Ferro F.E. Jr, Geib R.W., Fox M.T., Kozak S.L., Kabat D. Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host range restrictions for erythroleukemia. Journal of Virology. 69:1995;856-863.
34. Tambourin P., Wendling F., Moreau-Gachelin F., Charon M., Bacau-Varlet P. Friend leukemia: a multistep malignant disease. Rossi G.B. Vivo and In Vitro Erythropoiesis: The Friend System. 1980;127-138 Elsevier, Amsterdam.
35. Friend C., Haddad J.R. Tumor formation with transplants of spleen or liver from mice with virus-induced leukemia. Journal of the National Cancer Institute. 25:1960;1279-1289.
36. Friend C., Pateleia M.C., DeHarven E. Erythrocytic maturation in vitro of murine (Friend) virus-induced leukemia cells. National Cancer Institute Monograph. 288:1966;505-520.
37. Marks P.A., Rifkind R.A. Erythroleukemic differentiation. Annual Review of Biochemistry. 47:1978;419-448.
38. Friend C., Sher W., Holland J.G., Sato T. Hemoglobin synthesis in murine virus-induced leukemia cells in vitro: stimulation of erythroid differentiation by dimethylsulfoxide. Proceedings of the National Academy of Sciences of the USA. 68:1971;378-382.
39. Wolff L., Ruscetti S. The spleen focus-forming virus (SFFV) envelope gene, when introduced into mice in the absence of other SFFV genes, induces acute erythroleukemia. Journal of Virology. 62:1988;2158-2163.
40. Aizawa S., Suda Y., Furuta Y., Yagi T., Takeda N., Watanabe N., Nagayoshi M., Ikawa Y. Env-derived gp55 gene of Friend spleen focus-forming virus specifically induces neoplastic proliferation of erythroid progenitor cells. EMBO Journal. 9:1990;2107-2116.
41. Amanuma H., Katori A., Obata M., Sagata N., Ikawa Y. Complete nucleotide sequence of the gene for the specific glycoprotein (gp55) of Friend spleen focus-forming virus. Proceedings of the National Academy of Sciences of the USA. 80:1983;3913-3917.
42. Clark S.P., Mak T.W. Complete nucleotide sequences of an infectious clone of Friend spleen focus-forming provirus: gp55 is an envelope fusion glycoprotein. Proceedings of the National Academy of Sciences of the USA. 80:1983;5037-5041.
43. Wolff L., Scolnick E., Ruscetti S. Envelope gene of the Friend spleen focus-forming virus: deletion and insertions in 3′ gp70/p15E-encoding region have resulted in unique features in the primary structure of its protein product. Proceedings of the National Academy of Sciences of the USA. 80:1983;4718-4722.
44. Troxler D.H., Scolnick E.M. Rapid leukemia induced by cloned Friend strain of replicating murine type-C virus. Virology. 85:1978;17-27.
45. Watanabe N., Nishi M., Ikawa Y., Amanuma H. A deletion in the Friend spleen focus-forming virus env gene is necessary for its product (gp55) to be leukemogenic. Journal of Virology. 64:1990;2678-2686.
46. Srinivas R.V., Kilpatrick D.R., Compans R.W. Intracellular transport and leukemogenicity of spleen focus-forming virus envelope glycoprotein with altered transmembrane domains. Journal of Virology. 61:1987;4007-4011.
47. Amanuma H., Watanabe N., Nishi M., Ikawa Y. Requirement of the single base insertion at the 3′ end of the env-related gene of Friend spleen focus-forming virus for pathogenic activity and its effect on localization of the glycoprotein product (gp55). Journal of Virology. 63:1989;4824-4833.
48. Watanabe N., Nishi M., Ikawa Y., Amanuma H. Conversion of Friend mink cell focus-forming virus to Friend spleen focus-forming virus by modification of the 3′ half of the env gene. Journal of Virology. 65:1991;132-137.
49. Watanabe N., Yugawa T., Ikawa Y., Amanuma H. Both the changes of six amino acids and the C-terminal truncation caused by a one-base insertion in the defective env gene of Friend spleen focus-forming virus significantly affect the pathogenic activity of the encoded leukemogenic membrane glycoprotein (gp55). Journal of Virology. 69:1995;7606-7611.
50. Friedrich R., Friedrich U., Maennle G. Construction and properties of an 'artificial' spleen focus-forming virus. Virology. 183:1991;343-350.
51. Yugawa T., Amanuma H. Pathogenicity of a mutant Friend spleen focus-forming virus encoding an Env-like membrane glycoprotein (gp55) with substitution by a xenotropic murine leukemia virus Env gp70 sequence. Microbiology and Immunology. 42:1998;335-339.
52. Srinivas R.V., Kilpatrick D.R., Tucker S., Rui Z., Compans R.W. The hydrophobic membrane-spanning sequences of the gp52 glycoprotein are required for the pathogenicity of Friend spleen focus-forming virus. Journal of Virology. 65:1991;5272-5280.
53. Srinivas R.V., Rui Z., Compans R.W. A carboxy-terminal mutant spleen focus-forming virus (SFFV) envelope glycoprotein is transport-competent, but non-leukemogenic. Virus Research. 26:1992;57-69.
54. Rau S., Geyer R., Friedrich R.W. The role of gp55 N-glycosylation in pathogenesis of Friend spleen focus-forming virus. Journal of General Virology. 74:1993;699-705.
55. Wang Y., Kayman S.C., Li J-P., Pinter A. Erythropoietin receptor (EpoR)-dependent mitogenicity of spleen focus-forming virus correlates with viral pathogenicity and processing of env protein but not with formation of gp52-EpoR complexes in the endoplasmic reticulum. Journal of Virology. 67:1993;1322-1327.
56. Chung S., Wolff L., Ruscetti S.K. Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth. Proceedings of the National Academy of Sciences of the USA. 86:1989;7957-7960.
57. Wolff L., Kaminchik J., Hankins W.D., Ruscetti S.K. Sequence comparisons of the anemia- and polycythemia-inducing strains of Friend spleen focus-forming virus. Journal of Virology. 53:1985;570-578.
58. Dresler S., Ruta M., Murray M.J., Kabat D. Glycoprotein encoded by the Friend spleen focus-forming virus. Journal of Virology. 30:1979;564-575.
59. Ruscetti S., Linemeyer D., Feild J., Troxler D., Scolnick E.M. Characterization of a protein found in cells infected with the spleen focus-forming virus that shares immunological cross-reactivity with the gp70 found in mink cell focus-inducing virus particles. Journal of Virology. 30:1979;787-798.
60. Ruta M., Clarke S, Boswell B., Kabat D. Heterogeneous metabolism and subcellular localization of a potentially leukemogenic membrane glycoprotein encoded by Friend erythroleukemia virus. Journal of Biological Chemistry. 257:1982;126-134.
61. Srinivas R.V., Compans R.W. Membrane association and defective transport of spleen focus-forming virus glycoproteins. Journal of Biological Chemistry. 258:1983;14,718-14,724.
62. Ruscetti S.K., Feild J.A., Scolnick E.M. Polycythemia- and anaemia-inducing strains of spleen focus-forming virus differ in post-translational processing of envelope-related glycoprotein. Nature. 294:1981;663-665.
63. Gliniak B.C., Kabat D. Leukemogenic membrane glycoprotein encoded by Friend spleen focus-forming virus: transport to cell surfaces and shedding are controlled by disulfide-bonded dimerization and by cleavage of a hydrophobic membrane anchor. Journal of Virology. 63:1989;3561-3568.
64. Pinter A., Honnen W.J. Biochemical characterization of cell-associated and extracellular products of the Friend spleen focus-forming env gene. Virology. 173:1989;136-143.
65. Kilpatrick D.R., Srinivas R.V., Stephens E.B., Compans R.W. Effects of deletion of the cytoplasmic domain upon surface expression and membrane stability of a viral envelope glycoprotein. Journal of Biological Chemistry. 262:1987;16,116-16,121.
66. Srinivas R.V., Tucker S.P., Kilpatrick D.R., Compans R.W. A 585-bp deletion found in the spleen focus-forming virus (SFFV) env gene is responsible for the defective intracellular transport of SFFV gp52. Virology. 188:1992;181-192.
67. Kilpatrick D.R., Srinivas R.V., Compans R.W. The spleen focus-forming virus envelope glycoprotein is defective in oligomerization. Journal of Biological Chemistry. 264:1989;10,732-10,737.
68. Yang Y., Tojo A., Watanabe N., Amanuma H. Oligomerization of Friend spleen focus-forming virus (SFFV) env glycoproteins. Virology. 177:1990;312-316.
69. Pinter A., Honnen W.J. The mature form of the Friend spleen focus-forming virus envelope protein, gp65, is efficiently secreted from cells. Virology. 143:1985;646-650.
70. Ruta M., Bestwick R., Machida C., Kabat D. Loss of leukemogenicity caused by mutations in the membrane glycoprotein structural gene of Friend spleen focus-forming virus. Proceedings of the National Academy of Sciences of the USA. 80:1983;4704-4708.
71. Li J., Bestwick R.K., Spiro C., Kabat D. The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. Journal of Virology. 61:1987;2782-2792.
72. Ferro F.E. Jr, Kozak S.L., Hoatlin M.E., Kabat D. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. Journal of Biological Chemistry. 268:1993;5741-5747.
73. Ruscetti S.K., Ruscetti F.W. Apparent Epo-independence of erythroid cells infected with the polycythemia-inducing strain of Friend spleen focus-forming virus is not due to Epo production or change in number or affinity of Epo receptors. Leukemia. 3:1989;703-707.
74. McDonald J.D., Lin F., Goldwasser E. Cloning, sequencing and evolutionary analysis of the mouse erythropoietin gene. Molecular and Cellular Biology. 6:1986;842-848.
75. Shoemaker C.B., Mistock L.D. Murine erythropoietin gene: cloning, expression and human gene homology. Molecular and Cellular Biology. 6:1986;849-858.
76. D'Andrea A.D., Lodish H.F., Wong G.G. Expression cloning of the murine erythropoietin receptor. Cell. 57:1989;277-285.
77. D'Andrea A.D., Yoshimura A., Youssoufian J., Zon L.I., Koo J-W., Lodish H.F. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Molecular and Cellular Biology. 11:1991;1980-1987.
78. Yoshimura A., D'Andrea A.D., Lodish H.F. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proceedings of the National Academy of Sciences of the USA. 87:1990;4139-4143.
79. Yoshimura A., Zimmers T., Neumann D., Longmore G., Yoshimura Y., Lodish H.F. Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor. Journal of Biological Chemistry. 267:1992;11,619-11,625.
80. Zon L.I., Moreau J-F., Koo J-W., Mathey-Prevot B., D'Andrea A.D. The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein. Molecular and Cellular Biology. 12:1992;2949-2957.
81. Li J-P., Hu H-O., Niu Q-T., Fang C. Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55. Journal of Virology. 69:1995;1714-1719.
82. Casadevall N., Lacombe C., Muller O., Gisselbrecht S., Mayeux P. Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells). Journal of Biological Chemistry. 266:1991;16,015-16,020.
83. Yugawa T., Amanuma H. Impaired activation and binding of the erythropoietin receptor by a mutant gp55 of Friend spleen focus-forming virus, which has a cytoplasmic domain. Virology. 246:1998;232-240.
84. Sawyer S.T., Hankins W.D. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation. Proceedings of the National Academy of Sciences of the USA. 90:1993;6849-6853.
85. Kishi A., Chiba T., Sugiyama M., Machide M., Nagata Y., Amanuma H., Taira H., Katsumata T., Tudokoro K. Erythropoietin receptor binds to Friend virus gp55 through other membrane components. Biochemical and Biophysical Research Communications. 192:1993;1131-1138.
86. Tarr K., Watowich S.S., Longmore G.D. Cell surface organization of the erythropoietin receptor complex differs depending on its mode of activation. The Journal of Biological Chemistry. 272:1997;9099-9107.
87. Ihle J.N. Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells. Advances in Cancer Research. 68:1996;23-65.
88. Witthuhn B.A., Quelle F.W., Silvennoinen O., Yi T., Tang B., Miura O., Ihle J.N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 74:1993;227-236.
89. Watowich S.S., Hilton D.J., Lodish H.F. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Molecular and Cellular Biology. 14:1994;3535-3549.
90. Damen J.E., Wakao H., Miyajima A., Krosl J., Humphries R.K., Cutler R.L., Krystal G. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO Journal. 14:1995;5557-5568.
91. Gobert S., Chretien S., Gouilleux F., Muller O., Pallard C., Dusanter-Fourt I., Groner B., Lacombe C., Gisselbrecht S., Mayeux P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO Journal. 15:1996;2434-2441.
92. Quelle F.W., Wang D., Nosaka T., Thierfelder W.E., Stravopodis D., Weinstein Y., Ihle J.N. Erythropoietin induces the activation of STAT5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Molecular and Cellular Biology. 16:1996;1622-1631.
93. Klingmüller U., Bergelson S., Hsiao J.G., Lodish H.F. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5. Proceedings of the National Academy of Sciences of the USA. 93:1996;8324-8328.
94. Gouilleux F., Pallard C., Dusanter-Fourt I., Wakao H., Haldosen L-A., Norstedt G., Levy D., Groner B. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO Journal. 14:1995;2005-2013.
95. Ohashi T., Masuda M., Ruscetti S.K. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood. 85:1995;1454-1462.
96. Penta K., Sawyer S.T. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. The Journal of Biological Chemistry. 270:1995;31,282-31,287.
97. Wakao H., Harada N., Kitamura T., Mui A.L-F., Miyajima A. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO Journal. 11:1995;2527-2535.
98. Damen J.E., Liu L., Cutler R.L., Krystal G. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood. 82:1993;2296-2303.
99. Barber D.L., Corless C.N., Xia K., Roberts T.M., D'Andrea A.D. Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells. Blood. 89:1997;55-64.
100. Carroll M.P., Spivak J.L., McMahon M., Weich N., Rapp U.F. Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. Journal of Biological Chemistry. 266:1991;14,964-14,969.
101. GAP tyrosine phosphorylation in human erythroleukemia cells. Journal of Biological Chemistry. 267:1992;8293-8298.
102. Miura Y., Miura O., Ihle J.N., Aoki N. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. Journal of Biological Chemistry. 269:1994;29,962-29,969.
103. Damen J.E., Mui A.L-F., Puil L., Pawson T., Krystal G. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood. 81:1993;3204-3210.
104. He T.C., Zhuang H., Jiang N., Waterfield M.D., Wojchowski D.M. Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood. 82:1993;3530-3538.
105. Mayeux P., Dusanter-Fourt I., Muller O., Mauduit P., Sabbah M., Druker B., Vainchenker W., Fischer S., Lacombe C., Gisselbrecht S. Erythropoietin induces the association of phosphatidylinositol 3′-kinase with a tyrosine-phosphorylated complex containing the erythropoietin receptor. European Journal of Biochemistry. 216:1993;821-828.
106. Miura O., Nakamura N., Ihle J.N., Aoki N. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. Journal of Biological Chemistry. 269:1994;614-620.
107. Klingmüller U., Wu H., Hsiao J.G., Toker A., Duckworth B.C., Cantley L.C., Lodish H.F. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proceedings of the National Academy of Sciences of the USA. 94:1997;3016-3021.
108. Verdier F., Chrétien S., Billat C., Gisselbrecht S., Lacombe C., Mayeux P. Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. The Journal of Biological Chemistry. 272:1997;26,173-26,178.
109. Miura O., Miura Y., Nakamura N., Quelle F.W., Witthuhn B.A., Ihle J.N., Aoki N. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with JAK2-mediated growth signaling from the erythropoietin receptor. Blood. 84:1994;4135-4141.
110. Odai H., Sasaki K., Iwamatsu A., Hanazono Y., Tanaka T., Mitani K., Yazaki Y., Hirai H. The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. Journal of Biological Chemistry. 270:1995;10,800-10,805.
111. Barber D.L., Mason J.M., Fukazawa T., Reedquist K.A., Druker B.J., Band H., D'Andrea A.D. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins. Blood. 89:1997;3166-3174.
112. Tilbrook P.A., Ingley E., Williams J.H., Hibbs M.L., Klinken S.P. Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. EMBO Journal. 16:1997;1610-1619.
113. Foltz I.N., Schrader J.W. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood. 89:1997;3092-3096.
114. Nagata Y., Nishida E., Todokoro K. Activation of JNK signaling pathway by erythropoietin, thrombopoietin and interleukin-3. Blood. 89:1997;2664-2669.
115. Klingmüller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of the hematopoietic protein tyrosine phosphatase SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
116. Tauchi T., Damen J.E., Toyama K., Feng G-S., Broxmeyer H.E., Krystal G. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood. 87:1996;4495-4501.
117. Damen J.E., Liu L., Rosten P., Humphries R.K., Jefferson A.B., Majerus P.W., Krystal G. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proceedings of the National Academy of Sciences of the USA. 93:1996;1689-1693.
118. Linnekin D., Evans G.A., D'Andrea A., Farrar W.L. Association of the erythropoietin receptor with protein tyrosine kinase activity. Proceedings of the National Academy of Sciences of the USA. 89:1992;6237-6241.
119. Showers M.O., Moreau J-F., Linnekin D., Druker B., D'Andrea A.D. Activation of the erythropoietin receptor by the Friend spleen focus-forming virus gp55 glycoprotein induces constitutitive protein tyrosine phosphorylation. Blood. 80:1992;3070-3078.
120. Ohashi T., Masuda M., Ruscetti S.K. Activation of Stat-related DNA binding factors by erythropoietin and the spleen focus-forming virus. Current Topics in Microbiology and Immunology. 211:1996;224-231.
121. Ohashi T., Masuda M., Ruscetti S.K. Constitutive activation of Stat-related DNA-binding proteins in erythroid cells by the Friend spleen focus-forming virus. Leukemia. 11:1997;251-254.
122. Yamamura Y., Senda H., Kageyama Y., Matsuzaki T., Noda M., Ikawa Y. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Molecular and Cellular Biology. 18:1998;1172-1180.
123. Muszynski K.W., Ohashi T., Hanson C., Ruscetti S.K. Both the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus induce constitutive activation of the Raf-1 mitogen-activated protein kinase signal transduction pathway. Journal of Virology. 72:1998;919-925.
124. Spangler R.S., Bailey C., Sytkowski A.J. Erythropoietin increases c-myc mRNA by a protein kinase C-dependent pathway. Journal of Biological Chemistry. 266:1991;681-684.
125. Shimizu R., Komatsu N., Nakamura Y., Nakauchi H., Nakabeppu Y., Miura Y. Role of c-jun in the inhibition of erythropoietin receptor-mediated apoptosis. Biochemical and Biophysical Research Communications. 222:1996;1-6.
126. Tsuda H., Huang R.W., Konishi M., Mizukami T., Yoko-o Y., Hasegawa M., Sakaguchi M., Kawakita M., Takatsuki K. A new system that analyzes erythropoietin-mediated early signal transduction: transfection of the c-fos enhancer promoter-luciferase gene into a murine erythroid cell line. European Journal of Haematology. 52:1994;73-79.
127. Quelle F.W., Wang D., Nosaka T., Thierfelder W.E., Stravopodis D., Weinstein Y., Ihle J.N. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Molecular and Cellular Biology. 16:1996;1622-1631.
128. Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N.A., Gilbert D.J., Copeland N.G., Hara T., Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin3 and erythropoietin receptors. EMBO Journal. 14:1995;2816-2826.
129. Yoshimura A., Ichihara M., Kinjyo I., Moriyama M., Copeland N.G., Gilbert D.J., Jenkins N.A., Hara T., Miyajima A. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO Journal. 15:1996;1055-1063.
130. Patel H.R., Sytkowski A.J. Erythropoietin activation of AP1 (Fos/Jun). Experimental Hematology. 23:1995;619-625.
131. Bergelson S., Klingmüller U., Socolovsky M., Hsiao J.G., Lodish H.F. Tyrosine residues within the intracellular domain of the erythropoietin receptor mediate activation of AP-1 transcription factors. Journal of Biological Chemistry. 273:1998;2396-2401.
132. Barber D.L., DeMartino J.C., Showers M.O., D'Andrea A.D. A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation. Molecular and Cellular Biology. 14:1994;2257-2265.
133. Philo J.S., Aoki K.H., Arakawa T., Narhi L.O., Wen J. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. Biochemistry. 35:1996;1681-1691.
134. Longmore G.D., Lodish H.F. An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene. Cell. 67:1991;1089-1102.
135. Watowich S.S., Yoshimura A., Longmore G.D., Hilton D.J., Yoshimura Y., Lodish H.F. Homodimerization and constitutive activation of the erythropoietin receptor. Proceedings of the National Academy of Sciences of the USA. 89:1992;2140-2144.
136. Schneider H., Chaovapong W., Matthews D.J., Karkaria C., Cass R.T., Zhan H., Boyle M., Lorenzini T., Elliott S.G., Giebel L.B. Homodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursors. Blood. 89:1997;473-482.
137. Wrighton N.C., Farrell F.X., Chang R., Kashyap A.K., Barbone F.P., Mulcahy L.S., Johnson D.L., Barrett R.W., Jolliffe L.K., Dower W.J. Small peptides as potent mimetics of the protein hormone erythropoietin. Science. 273:1996;458-463.
138. Wrighton N.C., Balasubramanian P., Barbone F.P., Kashyap A.K., Farrell F.X., Jolliffe L.K., Barrett R.W., Dower W.J. Increased potency of an erythropoietin peptide mimetic through covalent dimerization. Nature Biotechnology. 15:1997;1261-1265.
139. Qiu H., Belanger A., Yoon H-W.P., Bunn H.F. Homodimerization restores biological activity to an inactive erythropoietin mutant. The Journal of Biological Chemistry. 273:1998;11,173-11,176.
140. Gomez-Lucia E., Zhi Y., Nabavi M., Zhang W., Kabat D., Hoatlin M.E. An array of novel murine spleen focus-forming viruses that activate the erythropoietin receptor. Journal of Virology. 72:1998;3742-3750.
141. r resistance gene. Proceedings of the National Academy of Sciences of the USA. 87:1990;9985-9989.
142. Ahlers N., Hunt N., Just U., Laker C., Ostertag W., Nowock J. Selectable retrovirus vectors encoding Friend virus gp55 or erythropoietin induce polycythemia with different phenotypic expression and disease progression. Journal of Virology. 68:1994;7235-7243.
143. Longmore G.D., Pharr P.N., Lodish H.F. A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells. Molecular and Cellular Biology. 14:1994;2266-2277.
144. 3H) thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation. Journal of the National Cancer Institute. 77:1986;241-245.
145. r-mediated resistance to Friend virus-induced erythroleukemia. Journal of Virology. 66:1992;3652-3660.
146. rr host resistance encodes a small glycoprotein that dimerizes, is processed to cell surfaces, and specifically activates erythropoietin receptors. Journal of Virology. 67:1993;2611-2620.
147. Hoatlin M.E., Ferro F.E. Jr, Kozak S.L., Kabat D. A Friend virus mutant encodes a small glycoprotein that causes erythroleukemia. Journal of Virology. 68:1994;4053-4056.
148. Moreau-Gachelin F., Tavitian A., Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukemias. Nature. 331:1988;277-280.
149. Paul R., Schuetze S., Kozak S.L., Kabat D. A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization. Journal of Virology. 63:1989;4958-4961.
150. Moreau-Gachelin F., Ray D., Mattei M., Tambourin P., Tavitian A. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene. 4:1989;1449-1456.
151. Paul R., Schuetze S., Kozak S.L., Kozak C., Kabat D. The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor PU.1. Journal of Virology. 65:1991;464-467.
152. Schuetze S., Stenberg P.E., Kabat D. The ets-related transcription factor PU.1 immortalizes erythroblasts. Molecular and Cellular Biology. 13:1993;5670-5678.
153. Moreau-Gachelin F., Wendling F., Molina T., Denis N., Titeux M., Grimber G., Briand P., Vainchenker W., Tavitian A. Spi-1/PU.1 transgenic mice develop
154. Schuetze S., Paul R., Gliniak B.C., Kabat D. Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells. Molecular and Cellular Biology. 12:1992;2967-2975.
155. Dolores Delgado M., Hallier M., Meneceur P., Tavitian A., Moreau-Gachelin F. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides. Oncogene. 9:1994;1723-1727.
156. Gauthier J-M., Bourachot B., Doucas V., Yaniv M., Moreau-Gachelin F. Functional interferences between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO Journal. 12:1993;5089-5096.
157. Galson D.L., Hensold J.O., Bishop T.R., Schalling M., D'Andrea A.D., Jones C., Auron P.E., Housman D.E. Mouse β-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Molecular and Cellular Biology. 13:1993;2929-2941.
158. Quang C.T., Wessely O., Pironin M., Beug H., Ghysdael J. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation. The EMBO Journal. 16:1997;101-115.
159. Mowat M., Cheng A., Kimura N., Bernstein A., Benchimol S. Rearrangements of cellular p53 gene in erythroleukemic cells transformed by Friend virus. Nature. 314:1985;633-636.
160. Ben-David Y., Prideaux V.R., Chow V., Benchimol S., Bernstein A. Inactivation of the p53 oncogene by internal deletion of retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene. 3:1988;179-185.
161. Munroe D.G., Peacock J.W., Benchimol S. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Molecular and Cellular Biology. 10:1990;3307-3313.
162. Lavigueur A., Bernstein A. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus. Oncogene. 6:1991;2197-2201.